In the HWSC sample, there was no statistically significant association between the genetic variants of SLC2A9 and the CHD risk, after adjusting for possible confounding variables (age, sex, uric acid levels, consumption of anti-inflammatory drugs and diuretics, creatinine concentrations and menopause) (Supplementary Table S7). Here, SLC2A9 is linked to coronary artery disorder.